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Abstract
Background: Fungal biofilms are more resistant to anti-fungal drugs than organisms in planktonic form.
Traditionally, susceptibility of biofilms to anti-fungal agents has been measured using the 2,3-bis(2-methoxy-4-nitro-
5-sulfophenyl)-2H-tetrazolium-5-carboxyanilide (XTT) assay, which measures the ability of metabolically active cells
to convert tetrazolium dyes into colored formazan derivatives. However, this assay has limitations when applied to
high C. albicans cell densities because substrate concentration and solubility are limiting factors in the reaction.
Because mature biofilms are composed of high cell density populations we sought to develop a quantitative real-
time RT-PCR assay (qRT-PCR) that could accurately assess mature biofilm changes in response to a wide variety of
anti-fungal agents, including host immune cells.
Results: The XTT and qRT-PCR assays were in good agreement when biofilm changes were measured in
planktonic cultures or in early biofilms which contain lower cell densities. However, the real-time qRT-PCR assay
could also accurately quantify small-medium size changes in mature biofilms caused by mechanical biomass
reduction, antifungal drugs or immune effector cells, that were not accurately quantifiable with the XTT assay.
Conclusions: We conclude that the qRT-PCR assay is more accurate than the XTT assay when measuring small-
medium size effects of anti-fungal agents against mature biofilms. This assay is also more appropriate when mature
biofilm susceptibility to anti-fungal agents is tested on complex biological surfaces, such as organotypic cultures.
Background
Microbial biofilms have an innate resistance to antimi-
crobials and immune attack and have been recently
linked to many recalcitrant or recurrent infections [1-3].
The ability of C. albicans to form biofilms on prosthetic
devices and mucosal surfaces is believed to be intimately
associated with its ability to trigger systemic or mucosal
infection [4-6]. Therefore the development of novel
anti-biofilm agents is of paramount importance in the
treatment or prevention of these infections.
Susceptibility of Candida biofilms to anti-fungal
agents is frequently measured using colorimetric assays
that estimate metabolic activity of viable cells residing in
biofilms [2,6,7]. Such assays have also been widely used
to assess viable cell numbers [8-16]. In these assays
metabolically active cells convert tetrazolium dyes into
colored formazan derivatives that can be measured by a
multi-well scanning spectrophotometer [9,14,16-21]. A
key component of one of the formazan assays is sodium
salt of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tet-
razolium-5-carboxyanilide, or XTT. Mitochondrial dehy-
drogenases of viable cells cleave the tetrazolium ring of
XTT yielding water-soluble orange formazan. The biore-
duction of XTT is inefficient and can be potentiated by
addition of an electron-coupling agent such as phena-
zine methosulfate [9,13,16,17,19,22], menadione
[2,13,16,19,22] or coenzyme Q0 (CoQ) [15,20,23].
The XTT assay has been used under various condi-
tions for viability assessment of different organisms
including mammalian cells, bacteria and fungi [19,24].
Its wide-spread use is due to the fact that it is simple,
fast, and does not require highly specialized equipment
other than a spectrophotometer. However, it is accurate
only if there is a linear relationship between cell meta-
bolic activity (or cell number) and colorimetric signal.
Thus, for the assay to be quantitative, it is important to
optimize several key experimental parameters (such as
cell number, concentration of XTT, type and concentra-
tion of electron-coupling agent) for every organism and
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any medium, provided the original work is properly cited.every experimental condition [5,12,13,15]. Assay optimi-
zation can be more challenging in mature biofilms since
metabolic activity and viable cell number may not be
linearly related [12,13]. In addition, colony counting
methods of viability assessment are not appropriate for
mature biofilms since they consist of multicellular
hyphal organisms encased in a polysaccharide matrix,
which hinders single cell colony growth. Given these
facts we sought to critically examine the limitations of
the XTT assay in measuring metabolic changes in
mature biofilms and develop a molecular assay based on
PCR for biofilm viability estimates that would overcome
these limitations.
Results
We first tried to optimize the XTT assay for a wide
range of Candida cell densities, which would represent
different stages of biofilm growth. As shown in
Figure 1A-B overall, a linear relationship between the
OD450 signal and yeast cell number was observed only
when yeast did not exceed 1 × 10
5 cells per well. Above
this cell density, significant changes in yeast cell number
(2-fold or greater) resulted in very small or undetectable
differences in OD450 values. This suggests that the
XTT assay would be of limited value in mature biofilms,
since C. albicans biofilms are frequently started by seed-
ing ≥1×1 0
5 yeast cells per well, in 96 well plates, and
grown for 48h or longer for biofilms to mature [2,6,28].
Increasing the concentration of XTT up to 2 mg/ml
(since XTT maximum solubility in water is 2.5 mg/ml)
d i dn o tr e s u l ti nac h a n g ei nO D 4 5 0w h e nt h es e e d i n g
yeast cell number was equal to or lower than 1 × 10
5
cells per well (Figure 1A). With yeast cell numbers
higher than 1 × 10
5 cells per well, increasing the con-
centration of XTT resulted in higher OD450 values,
which extended the linearity range only up to 2 × 10
5
c e l l sp e rw e l l .T h i ss u g g e s t st h a tX T Ts o l u b i l i t ya n d
final concentration are limiting factors in this reaction,
especially when large numbers of yeast cells are used to
start biofilms.
We also investigated if varying the concentration of
the electron-coupling agent CoQ (8-350 μM) would
allow us to extend the linearity range of the XTT signal.
XTT conversion rates were slower at lower concentra-
tions of CoQ, generating flat slopes (Figure 1B). How-
ever, we found that increasing the concentration of CoQ
would not increase the linearity range (Figure 1B). Read-
ing the plates at 490 nm as opposed to 450 nm or
increasing the XTT reaction time to 3 hours still did
not improve the linearity range (data not shown), since
reaction time in higher cell densities (>10
6 cells/well)
was typically very fast (less than 10 min). Collectively,
t h e s ed a t as u g g e s tt h a tt h eX T Ta s s a yc a n n o tb ea d e -
quately optimized to accommodate the cell numbers
present in mature biofilms.
To further address this issue we developed a molecu-
lar assay for biofilm assessment based on quantitation of
EFB1 gene transcripts in Candida cells, since the EF-1b
protein is critical in regulating cell protein translation
rates and growth [25]. The EFB1 primer pairs specifi-
cally amplified PCR products of the predicted size (136
bp) from C. albicans cDNA and gave no PCR product
when tested with HL-60 cell cDNA (data not shown).
To generate standard curves amplification of serially
diluted plasmid pEFB was monitored by fluorescence
versus cycle number curves. The assay could detect 1 fg
of pEFB, which is equivalent to 224.37 copies of pEFB.
Comparison of the two assays in quantifying viable cells
at a wide range of seeding cell densities showed that in
contrast to the XTT assay, which gave a flat colorimetric
signal for cell densities exceeding 4 × 10
5/30 mm
2 of sur-
face area, the new assay was able to quantify cells at den-
sities up to 8 × 10
7/30 mm
2 ( F i g u r e2 A - B ) .I nf a c t ,t w o
fold differences in viable cells were accurately quantified
at seeding densities ranging between 4 × 10
4-8 × 10
7/30
mm
2 with the qRT-PCR assay (Figure 2B).
To further assess the accuracy of the qRT-PCR assay
we compared it to viable colony counts, as well as to
the XTT assay, in detecting viability changes in plank-
tonic cells triggered by fluconazole or caspofungin. As
shown in Figure 3, the qRT-PCR assay could accurately
quantify a dose-dependent antifungal drug toxicity in
0
1
2
3
4
5
0 50 100 150 200 250 300 350 400 450 500
O
D
4
5
0
Candida cells/well, x1000
1mg/ml XTT
2mg/ml XTT
A
CoQ
0
1
2
3
4
5
6
7
0 100 200 300 400 500
Candida cells/well, x1000
O
D
4
5
0
350 mkM CoQ
220mkM CoQ
110mkM CoQ
35mkM CoQ
20mkM CoQ
8mkM CoQ
B
Figure 1 Effect of XTT assay parameters in the assessment of
C. albicans metabolic activity. Overnight planktonic cultures of C.
albicans yeast cells were seeded at 10
3-5 × 10
5 cells per well (30
mm
2 well surface area) and XTT assay was performed as described.
(A) Relationship between OD450 and Candida cell density at two
different XTT concentrations. (B) Effect of CoQ concentration on the
linearity range. A representative of three independent experiments
is shown.
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X T Ta n dC F Ua s s a y s( F i g u r e3 ) .O u rd a t aa l s os h o w
that the XTT and qRT-PCR assays were in good agree-
ment in quantifying toxicity in early biofilms triggered
by amphotericin B, whereas organisms killed by heat
produced no signal in the XTT or qRT-PCR assay (Fig-
ure 4). The latter was confirmed by the absence of
CFU’s in Sabouraud agar plates.
In order to compare the ability of the XTT and qRT-
PCR assays to accurately quantify changes in viable
mature biofilms, the biomass of biofilms grown for 48
hours was mechanically reduced and remaining biofilm
cells were assessed with the two assays. The XTT assay
showed that removal of 25-50% of the biofilm mass
resulted in a detectable decrease in OD450 values, com-
pared to intact biofilm. However, there were no signifi-
cant differences in the XTT signals resulting from
removal of different biofilm amounts, thus the XTT sig-
nal reduction was not commensurate to the reductions
in biomass. This shows that the XTT assay cannot accu-
rately quantify changes in mature biofilms (Figure 5A).
In contrast, the qRT-PCR assay showed excellent agree-
ment with reduction in the biofilm mass since 25%, 33%
and 50% biofilm removal resulted in an average of
25.8%, 35.4% and 49.8% reduction in the logarithmic
EFB1 transcript copy numbers, respectively (Figure 5B).
This confirms the ability of the real-time RT-PCR assay
to accurately measure reduction in biofilm metabolic
activity in mature biofilms.
Neutrophils exhibit potent candidacidal activities in
vitro [26,27] and interact with Candida biofilms forming
on mucosal tissues in vivo [4]. However there is a pau-
city of information regarding the outcome of the inter-
actions of neutrophils with biofilm organisms [28]. One
of the difficulties in studying these interactions in vitro
is the shortage of quantitative assays to accurately assess
neutrophil-inflicted damage in mature biofilms. There-
fore, we compared the ability of the two assays to detect
and quantify damage inflicted to early and mature bio-
films by HL-60 cells, a human neutrophil-like cell line.
When HL-60 cells interacted with early (3 h) biofilms,
significant biofilm damage (up to 80%) could be
detected at 10:1 effector to target ratio, regardless of the
assay used to measure viable biofilm changes (Figure
6A,B). Significant dose response differences to the
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Figure 2 Comparison of the XTT and real-time RT-PCR assay
signals with different seeding cell densities. Cells were seeded
at densities ranging between 4 × 10
4-8 × 10
7 cells per 30 mm
2 of
well surface area. (A) XTT assay data, expressed as OD450 units,
corresponding to each cell density. (B) Quantitative Real-Time RT-
PCR assay data, expressed as the mean log10 copy numbers of the
EFB1 transcript corresponding to each cell density. Means and
standard deviations of three independent experiments are shown.
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Figure 3 Comparison of the viable colony counts (CFU), XTT
and real-time RT-PCR assays in testing susceptibility of
planktonic cells to fluconazole (A) and caspofungin (B). Candida
yeast cells were exposed to a wide range of concentrations of the
antifungal drugs for 24 hours, followed by the CFU, XTT, or EFB1
qRT-PCR assays. Error bars represent SD of triplicate experiments.
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assays in early biofilms. Thus there was close agreement
between the two assays when early biofilms were tested.
However, in mature biofilms the XTT assay revealed
overall less than 25% fungal damage by immune effec-
tors and produced similar signals regardless of the num-
ber of effectors present, although there was a slight
indication of a dose response (Figure 6A). In contrast,
the real-time RT-PCR assay revealed a more robust dose
response of mature biofilms to immune effectors, with
damage to mature biofilms ranging approximately
between 10-45%, depending on the effector to target
ratio (Figure 6B). Nevertheless, regardless of the assay,
early biofilms exhibited significantly higher susceptibility
to neutrophil-like cells than mature biofilms, consistent
with a recent report [28].
We next compared the performance of the XTT and
qRT-PCR assays in quantifying viability changes in
mature biofilms grown on a three dimensional model of
the human oral mucosa. In order to do this we mea-
sured the effects of three antifungal drugs with different
mechanisms of action, as well as damage inflicted by
human leukocytes to mucosal biofilms. As expected, the
data showed that the XTT assay underestimates damage
to mature biofilms in this system, when smaller levels of
biofilm toxicity are measured, such as the ones obtained
with fluconazole, caspofungin or leukocytes (Figure 7A).
In contrast, the qRT-PCR assay revealed significant
Candida toxicity by all antifungal agents tested, which
was consistent with the limited levels of Candida tissue
invasion into the submucosal compartment in the pre-
sence of these agents (Figure 7B).
Discussion
Real-Time PCR technologies combine the sensitivity of
conventional PCR with the generation of a quantifiable
fluorescent signal and have been increasingly used to
assess viability of microorganisms [11,29-31]. Quantita-
tive real-time PCR allows for the detection of PCR
products produced at each step of the reaction, since
an increase in reporter fluorescent signal is directly
proportional to the number of amplicons generated.
As we have done in this work, PCR products can be
quantitated by generating a standard curve, in which
the absolute concentration of the plasmid standard is
known.
In this study we measured the effect of anti-fungal
agents against mature biofilms with a real-time RT-
PCR assay based on the quantification of EFB1
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Figure 4 Comparison of the XTT and qRT-PCR assays in the
assessment of early biofilm toxicity. Candida cells were seeded
at 10
5 cells per 30 mm
2 of well surface area and were incubated for
3 h at 37°C prior to exposure to amphotericin B (4 μg/ml, 4 h) or
heat (100°C, 1 h). Dark bars represent % biofilm damage, calculated
from change in mean OD450 values (XTT assay) and light bars
represent % damage calculated from change in mean EFB1
transcript copy numbers (qRT-PCR assay) under each experimental
condition, as described in the text. Error bars represent standard
deviations from three independent experiments.
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Figure 5 Comparison of the XTT and qRT-PCR assays in
assessing biomass reduction in mature biofilms. Biofilms were
seeded at 10
5 cells per 30 mm
2 of well surface area and were
incubated for 48 h. Prior to assessment, biofilms were either left
intact (0), or were mechanically reduced by 25%, 33% or 50%,
followed by the XTT assay (A) or qRT-PCR assay (B). Error bars
represent SD of triplicate experiments. Student t-test p values are
shown on the graph for each set of comparisons.
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gene is constitutively expressed under most growth
conditions and is frequently used as a normalization
gene in real-time RT-PCR quantification of other Can-
dida genes [32-37]. By designing sense primers that
span an intron splice site in the EFB1 sequence, we
expected that only intact mRNA molecules would serve
as a template in the RT-PCR assay and that these
molecules would be degraded following the death of
the organisms in the biofilm. Our results with this
molecular assay are consistent with our expectations
and show that it is highly quantitative in a wider range
of seeding fungal cell densities and that it more accu-
rately measures small-moderate mature biofilm changes
in response to stressors, compared to the traditional
XTT assay. We have also shown that this assay is parti-
cularly well suited for fungal biofilm viability estimates
in complex biological systems containing immune
effectors or mucosal cell cultures. This may be partly
due to the fact that mammalian cells also metabolize
XTT, which further limits substrate availability [19].
Compared to the XTT assay, the real-time assay is more
technically demanding, more prone to experimental errors
due to the multiple additional steps required in sample
preparation, more costly, and significantly more time con-
suming. Thus it should be reserved for susceptibility test-
ing of mature biofilms growing in complex biological
model systems containing immune effectors or mucosal
cells or used as a confirmatory assay when small changes
in mature biofilms are detected with the XTT assay.
Conclusions
In conclusion, our results indicate that the XTT assay has
to be applied with caution to biological systems contain-
ing large numbers of organisms alone or in combination
with mammalian cells. We also conclude that molecular
assessment of biofilms based on quantitation of EFB1
transcripts is a sensitive, reproducible and quantitative
method to measure the damaging effect of anti-fungal
agents against mature biofilms. The new quantitative
assay will aid in further investigations of the mechanisms
of Candida biofilm resistance to immune effector cells,
which are presently unknown. In addition the new assay
can be applied in quantitative assessment of mature
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Figure 6 Comparison of the two assays in quantifying immune
effector cell-mediated damage. Biofilms were seeded at 10
5 cells
per 30 mm
2 of well surface area and were incubated for 3 h or 48
h. HL-60 cells were subsequently added at two E:T ratios (10:1, dark
bars; 1:1, light bars). Early or mature biofilm changes were quantified
with the XTT (A) or qRT-PCR assays (B). % biofilm damage was
calculated using changes in mean OD450 signals or mean EFB1
transcript copy numbers, in the presence or absence of effectors, as
described in the text. Bars represent SD of triplicate HL-60
experiments. Student-t test p values are shown on the graph for
each set of comparisons.
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Figure 7 Biofilm susceptibility testing on a three dimensional
oral mucosal culture. Candida biofilms were grown for 24 h and
subsequently exposed to antifungal drugs (4 μg/ml amphotericin B,
70 μg/ml fluconazole or 8 μg/ml caspofungin) or neutrophil-like HL-
60 cells at an effector to target cell ratio of 10:1, for 24 additional
hours. (A) The effects of antifungal agents on biofilms were
quantitatively assessed by the XTT and qRT-PCR assays. Results
represent the mean ± SD of one representative experiment where
each condition was set up in triplicate. *p < 0.01 for comparison
between XTT and qRT-PCR in each condition. (B) PAS stain of
histologic sections showing the ability of the biofilm organisms to
invade into the submucosal compartment after exposure to
antifungal drugs or leukocytes. Black arrows: submucosal
compartment. White arrows: epithelial layer. Microorganisms appear
in dark blue.
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agents that are applied topically on mucosal surfaces.
Methods
Biofilm Growth
Strain C. albicans SC5314 was used in this study [38].
Yeast from frozen stocks were maintained on YPD agar
plates. For experimentation, yeast were inoculated into
YPD broth supplemented with 2% dextrose and grown
overnight at 24°C with shaking. Biofilms were grown by
seeding C. albicans blastoconidia in flat bottom well
plates (Becton Dickinson, Franklin Lakes, N.J.) and incu-
bating at 37°C from 3 h to 48 h. In preliminary work,
five different seeding media (YNB-0.5% glucose, DMEM,
DMEM-5%FBS, DMEM-10%FBS and RPMI-10%FBS)
were tested. Microscopic observations showed that the
best attachment of biofilms to plastic was achieved in
DMEM-10%FBS. Thus we used DMEM-10%FBS (Bio-
west/USA Scientific) in all experiments that followed.
To grow biofilms under conditions resembling in vivo
mucosal biofilm development a three dimensional
model of the human oral mucosa, developed in our
laboratory, was used which faithfully mimics the oral
mucosal tissue architecture in vivo [39]. Briefly, this
model system is composed of 3T3 fibroblasts embedded
in a biomatrix of collagen type I, overlaid by a multi-
layer of well-differentiated oral epithelial cells (OKF6/
TERT-1). C. albicans cells (1 × 10
6 yeast cells) were
added to the cultures apically in 100 μl of airlift medium
without FBS and antibiotics and incubated for 24 h. To
assess mucosal tissue damage and invasion tissues were
formalin-fixed, embedded in paraffin and 5 μm sections
were stained with the Periodic Acid Schiff (PAS) stain.
XTT Assay
The XTT assay was performed as we described earlier
[7]. Briefly, media were aspirated from biofilms and
were replaced with 100 μl/well of XTT solution (Sigma
Chemical Co., St. Louis, MO) containing Coenzyme Q0
(CoQ, Sigma Chemical Co., S t .L o u i s ,M O ) .F r e s hm i x -
tures of XTT and CoQ [1 mg/ml and 40 μg/ml (or 220
μM), respectively, unless otherwise indicated] were pre-
pared for each experiment. Plates were incubated at 37°
C for up to 3 hours, after which supernatants were
transferred into new plates, and optical densities (OD)
were measured by an Opsys Microplate Reader (Thermo
Labsystems, Franklin, MA) at 450-490 nm, with a 630
nm reference filter. When optical densities were higher
than the limits of the microplate reader, dilutions of the
supernatants in water were made.
Quantitative Real-Time RT-PCR Assay
To quantify changes in viable biofilms using an alterna-
tive approach, we measured mRNA expression of the
translation elongation factor-1b (EF-1b), encoded by the
EFB1 gene in C. albicans,b yr e a l - t i m eq u a n t i t a t i v eR T -
P C R .T h ec h o i c eo ft h i sg e n ew a sb a s e do nt h e s ef a c t s :
a) fungal cells transcriptionally regulate components of
their translational machinery according to external stres-
ses that affect protein synthesis [25,36]; b) the number
of EFB1 gene transcripts did not change significantly
during biofilm or planktonic growth between 3 h and 48
h( n o ts h o w n ) ;a n dc )EFB1 is frequently used as a
housekeeping gene in real-time RT-PCR quantification
of other Candida genes [29,32,33,36]. Total RNA from
biofilms was isolated using the RiboPure yeast kit
(Ambion, Inc.), according to the manufacturer’s instruc-
tions. RNA concentrations and purity were determined
by measuring the absorbance at 260 nm and 280 nm
(ND-1000 spectrophotometer, NanoDrop Technologies).
Equal amounts of RNA (3 μgi n2 0μl reactions) were
reverse transcribed with oligo(dT) primers using Super-
script reverse transcriptase II (Invitrogen).
Primers were based on the published sequence of the
EFB1 gene of C. albicans. Primer sequences used were
as follows: Forward: 5’- CAT TGA TGG TAC TAC
TGC CAC -3’;R e v e r s e :5 ’- TTT ACC GGC TGG CAA
GTC TT -3’. The forward primer spanned the sole
exon-exon boundary of EFB1, thus excluding amplifica-
tion of genomic C. albicans DNA. The uniqueness of
the primers for C. albicans EFB1 was determined using
the BLAST database http://www.tigr.org.
To generate standard curves for quantitative analyses
a pEFB plasmid was prepared as follows. A 136-bp
C. albicans EFB exon fragment, containing the target
sequence, was amplified with the above mentioned pri-
mers. PCR was performed in a DNA thermal cycler with
1 cycle of 5 min at 95°C; 40 cycles of 1 min at 95°C,
30 s at 62°C, 30 s at 72°C; and a final extension at 72°C
for 5 min. This fragment was ligated into the pCR 2.1
plasmid vector (3.931 kb) and transformed into One
Shot cells (Top10F’) using a TA cloning kit (Invitrogen).
Plasmids were digested with xhoI to generate a linear
template and purified with the PureYield™ Plasmid
Miniprep System (Promega). Plasmid concentrations
were determined spectrophotometrically and copy num-
bers calculated based on linear plasmid mass. Serial
plasmid dilutions (500 pg, 50 pg, 5 pg, 500 fg, 50 fg, 5
fg, 1 fg of DNA/μl) were then used to generate standard
curves for detection and quantification of EFB1 mRNA
by the iCycler iQ RT-PCR assay.
Real-time PCR was performed with an iCycler iQ real-
time PCR detection system (Bio-Rad). All PCR reaction
mixtures contained the following: 10 μl2×i Q ™ SYBR
®
Green Supermix (BioRad, Hercules, CA), 1 μlo ff i r s t -
strand cDNA reaction mixture or linear plasmid DNA,
0.1 μM of primers and H2O to bring the final volume to
20 μl. The program for amplification had an incubation
Xie et al. BMC Microbiology 2011, 11:93
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followed by 40 cycles of 95°C for 10 s and 62°C for 30 s.
Reactions to estimate transcript copy number were run
in duplicate from two biologic RNA replicates. Data were
analyzed using the iCycle iQ system software (BioRad).
Testing of planktonic cells
Candida cells were grown overnight in YPD broth as
described above. Cultures were adjusted to a cellular
density equivalent to 1.0 × 10
6 cells/ml and subjected to
caspofungin (CAS, Merck Research Laboratories, Rah-
way, N.J.) or fluconazole (FLU, Pfizer Inc., Sandwich,
United Kingdom) treatment for 24 h, at doses ranging
from 0.0625-1024 μg/ml [40,41]. Untreated cells served
as negative controls. Four replicates were included in
each experiment. The effects of the anti-fungals on
planktonic cells were measured by colony counts on
Sabouraud agar plates (CFU), or by the XTT and qRT-
PCR assays as described above.
Biofilm testing
To compare the ability of the two assays to quantify
changes in mature biofilms stemming from biomass
reduction, organisms were grown in 12 well plates for
48 h and their biomass was physically reduced by
removing 50%, 33% or 25% of the biofilm from the well
surface. To perform this, the round surface area of each
well was divided into two, three or four equal parts, and
removal of the biofilm from 1/2, 1/3 or 1/4 of the sur-
face area was accomplished with the help of a modified
rubber policeman, with a sweeping edge cut to the size
of the well radius. Remaining biofilm cells observed
microscopically were removed using a sterile glass suc-
tion tip. XTT and real-time RT-PCR measurements in
residual biofilms in these wells were subsequently com-
pared to intact biofilms.
To compare the ability of the two assays to quantify
changes in viable biofilms in response to different stres-
sors, biofilms grown on plastic were exposed to pharma-
cologic [amphotericin B (AMB), 4 μg/ml, 4 h],
environmental (100°C, 1 h) or immune cell stressors
and viability was measured by the XTT or qRT-PCR
assays. To quantify susceptibility to immune cell-
inflicted damage we used a neutrophil-like cell line (HL-
60, ATCC), as previously described [7]. Briefly, pre-acti-
vated HL-60 cells (1.25% DMSO for 7-9 days) were
added to biofilms at varying effector to target cell ratios,
based on seeding cell densities. After incubation at 37°C,
5% CO2 for 2 hours, media were aspirated, HL-60 cells
were lysed with sterile H2O, and fungal viability was
assessed with the XTT or qRT-PCR assays. Biofilms
grown on mucosal tissues were exposed to anti-fungal
drugs (4 μg/ml amphotericin B, 70 μg/ml fluconazole
or 8 μg/ml caspofungin [40,41]) or HL-60 cells for
24 hours, followed by mammalian cell lysis with sterile
water. This was followed by the XTT or qRT-PCR
assays. Anti-biofilm activity was calculated according to
the following formula: % fungal damage = (1-x/n)*100,
w h e r e×i st h eO D 4 5 0o rEFB1 transcript copy number
of experimental wells (C. albicans with stressors/effec-
tors) and n is the OD450 or EFB1 transcript copy num-
ber of control wells (C. albicans only). All experiments
were performed in triplicate.
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